It's quite hard to imagine another large-scale genetic study getting funded until this one reports, and the results have been studied by other groups. It might find something interesting that could be pursued with much smaller and more specific groups of patients and controls; or it might find...
They don't mean the smart meter, though. They're not the responsibility of householders, any more than traditional meters are.
The article shows an in-home display, a small gadget that if it were on public sale, you wouldn't expect to pay more than £20 for on Amazon. You don't need one in order...
I don't get it—the device in the picture isn't a smart meter, it's an in-home display.
The smart meter itself usually shows readings and the main meter definitely does, so unless people are unable to access either of these, how on God's green earth can they can have "no way of knowing how much...
It is a very impressive response. I'm a bit surprised at the 50% rate, I'd somehow imagined it might be more like two thirds or three quarters being invited to submit, but I'm sure that's only because I don't know enough about it.
I only know two people personally with ME, so I don't really...
Sadly not surprising in the least, I guess the same might be found in other countries too. It's not only treating physicians who need to reflect communities, it's the senior ones with the most influence on local and regional policy too.
Do we know much about why the numbers aren't as good as we'd hoped? Is it that quite a lot of folk haven't been asked to give DNA because of potential confounding conditions or unclear diagnosis? Or are there substantial numbers who showed initial interest, but either didn't complete a...
Pretty much reflects my feelings too. I suspect that, at least in my lifetime, the discovery of a biomarker reliable enough to gain acceptance might bring more social benefits than medical ones.
The importance of that shouldn't be underestimated, though. Whatever chronic illness a person has...
It's not the sort of thing that would very often get tested in the UK, at least by the NHS. I think the logic goes "Well, we wouldn't know what it meant anyway, so..."
These are things that really need to be accounted for in trial protocols. It's not easy—it might even be impossible in a short trial, because any intervention is likely to result in some behavioural changes at the outset—and researchers almost certainly underestimate just how much difference...
I've been thinking much the same, it must be difficult to get attention when you're researching such a marginal disease. He seems to be in a far from ideal situation as regards funding and support, and some of this is presumably targeted at potential funders and/or hosts for his lab. I don't...
Oh yes, same. They're such a bloody awkward shape, specially if you were clumsy to start with and now your fingers don't even have working joints. I've all on putting the passcode in when it decides it's gone off my fingerprint, let alone doing anything more intricate.
That's one of the...
Making a WhatsApp call to NZ would be no different to making the call on a mobile, though. You just press a different square on the screen.
If someone else had dialled up the call and then handed the phone to me, I wouldn't be able to tell you which I was using. The only reason I might choose...
Is it me, or are parts of that list from Prof Iwasaki a bit underwhelming?
Would it be very surprising if 94% of patients who said they were ill turned out to be ill, or if immunisation increased antibody responses, or if herpesviruses reactivated during illness, or if no increased...
The whole thing's barking. For a start, I bet there are a good many people who would qualify for PIP on a fair assessment but don't currently get it, either because they can't face the application process or they didn't have support to appeal when an initial application was turned down. This is...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.